To Evaluate the Efficacy and Safety of Gefitinib in Adjuvant Chemotherapy for Lung Adenocarcinoma
Clinical trial NCT03656393 · UNKNOWN
Trial details
- NCT number
- NCT03656393
- Sponsor
- Shenzhen People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-31
- Primary completion
- 2020-07-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.